742P First-in-human phase I study of INCAGN02385, a LAG-3 monoclonal antibody antagonist in patients with advanced malignancies
J.D. Powderly, O. Hamid, M.E. Gutierrez, A.S. Balmanoukian et autres
us (code pays fourni par la source)
9 citations
Annals of Oncology